- Connecting Healthcare & Clinical Research
Leave No Patients Behind™ Learn More
What We Do
Nominated as one of the top innovations in the industry, BlueCloud® is the first independent (real-time / single sign-on) global Professional Network. A global collaborative network connecting healthcare professionals and organizations (in a secure / private system), using networks including standards, education, technology, healthcare professional and patient networks to organize, centralize, and share verifiable information for business and compliance purposes.
Available in 162 countries and used by over 1 million healthcare professionals, Sponsors, CROs, research sites, hospitals, universities, and thousands of healthcare and clinical research stakeholders. Saving the industry millions of dollars by eliminating redundancies, expediting study start up as well as ensuring quality and compliance.
How We Give Back
The Research Literacy Connections for Tomorrow’s Cures campaign is a collaboration between the Center for Information and Study on Clinical Research Participation (CISCRP) and BlueCloud® by HealthCarePoint, for which BlueCloud® will donate one dollar per connection made on its online networking platform for CISCRP, in support of education and outreach to students and their families about clinical research. Dollar raised from the campaign will directly support the development of CISCRP’s Medical Heroes: A Traveling Museum Exhibit, which will engage elementary through high school age children and their families in 12 U.S. cities with interactive and experimental learning about the clinical research process and the role that clinical trials play in advancing public health. To learn more about CISCRP or the Medical Heroes Travel Museum, please visit www.ciscrp.org. Your BlueCloud® connections will make a difference for tomorrow’s cures!
- “In an effort to provide unsurpassed customer service, it is our goal to eliminate duplication for the sites. Ultimately, IntegReview believes that working with BlueCloud to collaborate between investigator sites and the IRBs will result in efficiencies realized by all players. We look forward to participating in this initiative.”Lynn Meyer - PresidentIntegReview IRB